The Knitting Needle and the Damage Done: Knitter's Magazine Issue 112: A Review
The Knitting Needle and the Damage Done: Knit n' Style December 2013: A Review
sustainability Archives - Josefin Waltin spinner
Fiber Preparation – Felting and Fiber Studio
The Knitting Needle and the Damage Done
A tailored, electronic textile conformable suit for large-scale spatiotemporal physiological sensing in vivo
Pin on Πλεκτά - Knitting (Βελόνες)
quot;I think it's really important to find that one thing that you look forward to every single day, something you can't wait to get home to do"
Made with Love; Tom Daley's a crafty influencer & a Dad- again
Brentuximab vedotin (BV) is an anti-CD30 antibody–drug conjugate approved to treat classical Hodgkin lymphoma (HL). BV-induced peripheral neurotoxicity (BVIN) is one of the greatest concerns for haematologists treating HL for several reasons. First, BVIN is highly frequent. Most patients receiving BV will experience some degree of BVIN, resulting in the primary reason for dose modification or discontinuation of HL therapy. Second, BV produces sensory, motor, and/or autonomic peripheral nerve dysfunction, which can present as severe, disabling forms of BVIN—predominantly motor—in some patients. Third, although largely reversible, BVIN may persist months or years after treatment and thereby become a major issue in HL survivorship. BVIN may, therefore, negatively affect the quality of life and work-life of often young patients with HL, in whom long-term survival is expected. Currently, the only strategy for BVIN includes dose adjustments and treatment discontinuation; however, this could interfere with LH therapy efficacy. In this setting, early recognition and adequate management of BVIN are critical in improving clinical outcomes. Careful neurologic monitoring may allow accurate diagnoses and gradation of ongoing forms of BVIN presentation. This review analysed current, available data on epidemiology, pathophysiology, patient- and treatment-related risk factors, clinical and neurophysiologic phenotypes, and management in patients with HL. Furthermore, this review specifically addresses limitations posed by BVIN assessments in clinical practice and provides skills and tools to improve neurologic assessments in these patients. Integrating this neurotoxic drug in clinical practice requires a multidisciplinary approach to avoid or minimise neurotoxicity burden in survivors of HL.
Cancers, Free Full-Text
Crochet Delicate Rose Hair Bow free pattern and video tutorial. The pattern is available for free on my blog and channel.
Crochet Delicate Rose Hair Bow Free Pattern